Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study

Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study

The purpose of this study was to explore the efficacy and safety of everolimus administered as a first-line treatment in newly diagnosed patients with metastatic or inoperable gastroenteropancreatic neuroendocrine tumors (GEP NETs). This phase II, multicenter, single-arm study included patients with...

Full description

Bibliographic Details
Main Authors: Anna Koumarianou, Dimitrios Pectasides, Georgia-Angeliki Koliou, Dimitrios Dionysopoulos, Dionysia Kolomodi, Christos Poulios, Maria Skondra, Joseph Sgouros, George Pentheroudakis, Gregory Kaltsas, George Fountzilas
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Biology
Subjects:
gep net
targeted therapy
octreotide lar
liver
lymph node
metastases
Online Access:https://www.mdpi.com/2079-7737/9/3/51

Internet

https://www.mdpi.com/2079-7737/9/3/51

Similar Items